All posts by Suresh Gopalan

You probably came here from my blog 'Hi-Brow Perspectives'. I am the CEO & Founder of ReSurfX, Inc. (@ReSurfX - resurfx.com). I am a Mechanical Engineer turned Biotechnologist recently transformed to my new avatar as an entrepreneur with the goal of ‘Building an Efficient and Healthy World’. In my quest to combine my various exposures and interests I am starting off my capitalistic pursuit with better data-based decisions in Pharma and Healthcare.

Did Andy Grove Leave a Fallacy for Life Sciences and Healthcare?

Yes, you guessed it right.. we are talking about the Andy Grove who left an indelible legacy through his role at the Intel corporation (together with the other two founders Robert Noyce and Gordon Moore) including as CEO for a decade, fueling the growth of Silicon Valley and the world at large. Now we got that cleared, we need to introduce some background on what is called the ‘Andy Grove Fallacy’ in a commentary in 2007.

Continue reading Did Andy Grove Leave a Fallacy for Life Sciences and Healthcare?

How does AI, Waymo self-driving taxi launch and Google indicate room for another search engine?

In exciting news this week Waymo™ the driverless car arm of Alphabet™ (the parent company of Google) launched its fully self-driving taxi service ‘Waymo One’ in Phoenix, Arizona. There is one catch though; the self-driving taxis each have a driver in them. What can we infer from this artificial intelligence (AI) enabled initiative and other offerings from the Alphabet conglomerate? Continue reading How does AI, Waymo self-driving taxi launch and Google indicate room for another search engine?

How do we prevent denial of available and deserved therapeutic options to patients?

I read this excellent post The Irrational Rationing of Health Care on LinkedIn by David Katz, that documents a case of denial of a treatment option to a patient because the payer considers that ‘not established as standard therapy for that cancer’ – as documented in their business criteria. As you would have guessed that the treatment option is a reasonably expensive one. This is an excellent article and an exemplary case for what I elaborate in previous blogs http://bit.ly/ACOSteadyState and http://bit.ly/sustainablehealthcare .

Continue reading How do we prevent denial of available and deserved therapeutic options to patients?

Adaptive social fitness – in all its abstractness

The above title can be re-framed as: How to always be working on the hottest themes throughout your life? 

stay hot

Warning: this is an exercise in trying to convey a seemingly abstract concept in completely abstract terms.

I happened to be in a meeting recently where panelists with a variety of backgrounds were discussing a red hot emerging theme – across the spectrum: from research until creating markets that don’t currently exist. Continue reading Adaptive social fitness – in all its abstractness

Just in time (JIT) vaccines and cures for Ebola and other sporadically emerging (and devastating) global infectious diseases

Do you know one of the advantages of being an engineer turned biotechnologist turned entrepreneur/capitalist? You can write a blog like the one below.

A few months ago, I was in an event that discussed approaches and challenges in tackling Ebola, organized by the MIT Enterprise Forum of Cambridge.

Image for JIT infectious Disease blog

Continue reading Just in time (JIT) vaccines and cures for Ebola and other sporadically emerging (and devastating) global infectious diseases

Leading Healthcare to a Better and Sustainable Future

This post is a complement and response to the post by Michael Greeley entitledBet the Jockey…Bet the Horse…and Bet the Track’ (hyperlinked).

PPPR

Michael Greeley is one of the nicest people I have met in the investment sector. The above well-written blog post is a ‘must read’. Continue reading Leading Healthcare to a Better and Sustainable Future

Why I am indifferent to the effects of sequestration on research funding

In the recent nine months we have been reading about the impact of sequestration on various aspects of life – from defense spending to basic biomedical research. Some articles highlight dramatic consequences.  I write this from the region of the USA (Boston/Cambridge area) that attracts the most amount of research funding from governmental sources per capita.

Peer Review
Peer Review*

Continue reading Why I am indifferent to the effects of sequestration on research funding